Australia markets closed

Krystal Biotech, Inc. (KRYS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
154.76-3.98 (-2.50%)
At close: 04:00PM EDT
154.76 0.00 (0.00%)
After hours: 04:01PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 4.53B
Enterprise value 4.00B
Trailing P/E 72.81
Forward P/E 178.57
PEG ratio (5-yr expected) N/A
Price/sales (ttm)47.39
Price/book (mrq)5.67
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.90
52-week change 380.05%
S&P500 52-week change 326.43%
52-week high 3189.97
52-week low 386.03
50-day moving average 3168.38
200-day moving average 3130.06

Share statistics

Avg vol (3-month) 3395.38k
Avg vol (10-day) 3327.92k
Shares outstanding 528.56M
Implied shares outstanding 629.29M
Float 820.75M
% held by insiders 112.76%
% held by institutions 191.37%
Shares short (15 Apr 2024) 42.45M
Short ratio (15 Apr 2024) 47.84
Short % of float (15 Apr 2024) 411.35%
Short % of shares outstanding (15 Apr 2024) 48.59%
Shares short (prior month 15 Mar 2024) 42.24M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 59.57%
Operating margin (ttm)12.85%

Management effectiveness

Return on assets (ttm)-4.97%
Return on equity (ttm)8.87%

Income statement

Revenue (ttm)95.95M
Revenue per share (ttm)3.45
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -50.61M
Net income avi to common (ttm)57.16M
Diluted EPS (ttm)2.18
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)538.26M
Total cash per share (mrq)18.85
Total debt (mrq)7.89M
Total debt/equity (mrq)0.99%
Current ratio (mrq)12.65
Book value per share (mrq)28.02

Cash flow statement

Operating cash flow (ttm)-46.76M
Levered free cash flow (ttm)-45.19M